S
AZN icon

SignatureFD’s AstraZeneca AZN Stock Holding History

SignatureFD’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,888
Closed -$6.05M – 3479
2025
Q4 		$6.05M Buy
32,888
+920
+3% +$161K 0.09% 77
2025
Q3 		$4.91M Buy
31,968
+1,851
+6% +$280K 0.08% 89
2025
Q2 		$4.21M Sell
30,117
-1,665
-5% -$233K 0.07% 100
2025
Q1 		$4.67M Buy
31,782
+1,709
+6% +$247K 0.09% 76
2024
Q4 		$3.94M Buy
30,073
+451
+2% +$63.1K 0.07% 90
2024
Q3 		$4.62M Buy
29,622
+1,023
+4% +$165K 0.09% 79
2024
Q2 		$4.46M Buy
28,599
+3,570
+14% +$537K 0.09% 73
2024
Q1 		$3.39M Buy
25,029
+1,578
+7% +$209K 0.07% 95
2023
Q4 		$3.16M Sell
23,451
-254
-1% -$33K 0.07% 97
2023
Q3 		$3.21M Buy
23,705
+1,394
+6% +$190K 0.08% 88
2023
Q2 		$3.19M Buy
22,311
+1,127
+5% +$166K 0.08% 85
2023
Q1 		$2.94M Buy
21,184
+770
+4% +$104K 0.08% 90
2022
Q4 		$2.77M Buy
20,414
+3,166
+18% +$397K 0.08% 85
2022
Q3 		$1.89M Sell
17,248
-1,953
-10% -$248K 0.06% 96
2022
Q2 		$2.54M Buy
19,201
+683
+4% +$89.6K 0.09% 77
2022
Q1 		$2.46M Buy
18,518
+2,756
+17% +$331K 0.07% 93
2021
Q4 		$1.84M Buy
15,762
+810
+5% +$95.3K 0.06% 119
2021
Q3 		$1.8M Buy
14,952
+2,165
+17% +$252K 0.06% 111
2021
Q2 		$1.53M Buy
12,787
+735
+6% +$80.6K 0.06% 120
2021
Q1 		$1.2M Buy
12,052
+243
+2% +$24.4K 0.05% 139
2020
Q4 		$1.18M Sell
11,809
-7,937
-40% -$841K 0.06% 118
2020
Q3 		$2.16M Buy
19,746
+9,248
+88% +$1.03M 0.12% 71
2020
Q2 		$1.11M Sell
10,498
-753
-7% -$77.8K 0.07% 103
2020
Q1 		$1M Sell
11,251
-5,180
-32% -$488K 0.09% 96
2019
Q4 		$1.64M Buy
16,431
+9,042
+122% +$851K 0.12% 75
2019
Q3 		$659K Buy
7,389
+912
+14% +$79.1K 0.05% 154
2019
Q2 		$535K Sell
6,477
-711
-10% -$55.7K 0.05% 167
2019
Q1 		$581K Hold
7,188
– – 0.05% 155
2018
Q4 		$546K Buy
7,188
+593
+9% +$46.3K 0.05% 157
2018
Q3 		$522K Buy
6,595
+95
+1% +$7.18K 0.05% 189
2018
Q2 		$456K Buy
6,500
+671
+12% +$48.3K 0.05% 193
2018
Q1 		$408K Buy
5,829
+1,027
+21% +$71.1K 0.05% 177
2017
Q4 		$333K Buy
4,802
+219
+5% +$14.8K 0.04% 216
2017
Q3 		$311K Buy
4,583
+885
+24% +$55.9K 0.04% 200
2017
Q2 		$252K Sell
3,698
-5,982
-62% -$391K 0.04% 221
2017
Q1 		$603K Buy
+9,680
New +$563K 0.09% 94
2016
Q4 		– Sell
-2,451
Closed -$161K – 322
2016
Q3 		$161K Buy
2,451
+1,481
+153% +$96.8K 0.02% 265
2016
Q2 		$59K Buy
970
+67
+7% +$3.89K 0.01% 430
2016
Q1 		$51K Buy
903
+8
+0.9% +$481 0.01% 421
2015
Q4 		$61K Buy
895
+230
+35% +$15.1K 0.01% 334
2015
Q3 		$42K Buy
665
+605
+1,008% +$39.8K 0.01% 374
2015
Q2 		$4K Buy
60
+50
+500% +$3.42K ﹤0.01% 774
2015
Q1 		$1K Sell
10
-80
-89% -$5.56K ﹤0.01% 850
2014
Q4 		$6K Buy
+90
New +$6.44K ﹤0.01% 563
2014
Q1 		– Sell
-325
Closed -$19K – 807
2013
Q4 		$19K Buy
+325
New +$17.7K 0.01% 361

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

SignatureFD's AZN Position: Q1 2026 in Review

SignatureFD sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 32,888 shares — an estimated $6.05M sold.

SignatureFD first reported a position in AZN in Q4 2013 and held it in 45 quarters. The position peaked at $6.05M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • SignatureFD reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • SignatureFD sold 32,888 AstraZeneca shares in Q1 2026, an estimated $6.05M.
  • SignatureFD first reported a position in AstraZeneca in Q4 2013 and held it in 45 quarters.
  • SignatureFD's AstraZeneca position peaked at $6.05M in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.